-
1
-
-
0028240063
-
Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells
-
Shewach D.S., Hahn T.M., Chang E., et al. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res. 54:1994;3218-3223.
-
(1994)
Cancer Res
, vol.54
, pp. 3218-3223
-
-
Shewach, D.S.1
Hahn, T.M.2
Chang, E.3
-
2
-
-
0030922494
-
Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2′,2′-difluoro-2′-deoxycytidine (gemcitabine)
-
Lawrence T.S., Chang E.Y., Hahn T.M., et al. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2′,2′-difluoro-2′-deoxycytidine (gemcitabine). Clin Cancer Res. 3:1997;777-782.
-
(1997)
Clin Cancer Res
, vol.3
, pp. 777-782
-
-
Lawrence, T.S.1
Chang, E.Y.2
Hahn, T.M.3
-
3
-
-
0030005273
-
Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine
-
Lawrence T.S., Chang E.Y., Hahn T.M., et al. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int J Radiat Oncol Biol Phys. 34:1996;867-872.
-
(1996)
Int J Radiat Oncol Biol Phys
, vol.34
, pp. 867-872
-
-
Lawrence, T.S.1
Chang, E.Y.2
Hahn, T.M.3
-
4
-
-
0033028180
-
The effect of 2′-2′ difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity
-
Rosier J.F., Beauduin M., Bruniaux M., et al. The effect of 2′-2′ difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity. Int J Radiat Biol. 75:1999;245-251.
-
(1999)
Int J Radiat Biol
, vol.75
, pp. 245-251
-
-
Rosier, J.F.1
Beauduin, M.2
Bruniaux, M.3
-
6
-
-
0019410935
-
Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil
-
Moertel C.G., Frytak S., Hahn R.G., et al. Therapy of locally unresectable pancreatic carcinoma A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil . Cancer. 48:1981;1705-1710.
-
(1981)
Cancer
, vol.48
, pp. 1705-1710
-
-
Moertel, C.G.1
Frytak, S.2
Hahn, R.G.3
-
7
-
-
0023262033
-
Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
-
Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 59:1987;2006-2010.
-
(1987)
Cancer
, vol.59
, pp. 2006-2010
-
-
-
8
-
-
0033006836
-
Cancer statistics, 1999
-
Landis S.H., Murray T., Bolden S., et al. Cancer statistics, 1999. CA Cancer J Clin. 49:1999;8-31.
-
(1999)
CA Cancer J Clin
, vol.49
, pp. 8-31
-
-
Landis, S.H.1
Murray, T.2
Bolden, S.3
-
9
-
-
0000046403
-
A phase I study of gemcitabine in combination with radiation therapy in patients with localized, unresectable pancreatic cancer
-
[Abstract]
-
McGinn C., Smith D., Szarka C., et al. A phase I study of gemcitabine in combination with radiation therapy in patients with localized, unresectable pancreatic cancer. [Abstract] Proc Am Soc Clin Oncol. 17:1998;264a.
-
(1998)
Proc Am Soc Clin Oncol
, vol.17
-
-
McGinn, C.1
Smith, D.2
Szarka, C.3
-
10
-
-
0000643645
-
A phase I study of preoperative gemcitabine with radiation therapy followed by postoperative gemcitabine in patients with localized, resectable pancreatic adenocarcinoma
-
[Abstract]
-
Hoffman J., McGinn C.J., Szarka C., et al. A phase I study of preoperative gemcitabine with radiation therapy followed by postoperative gemcitabine in patients with localized, resectable pancreatic adenocarcinoma. [Abstract] Proc Am Soc Clin Oncol. 17:1998;283a.
-
(1998)
Proc Am Soc Clin Oncol
, vol.17
-
-
Hoffman, J.1
McGinn, C.J.2
Szarka, C.3
-
11
-
-
0034880820
-
Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma
-
Wolff R.A., Evans D.B., Gravel D.M., et al. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res. 7:2001;2246-2253.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 2246-2253
-
-
Wolff, R.A.1
Evans, D.B.2
Gravel, D.M.3
-
12
-
-
0032815755
-
Maximizing therapeutic gain with gemcitabine and fractionated radiation
-
Mason K.A., Milas L., Hunter N.R., et al. Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys. 44:1995;1125-1135.
-
(1995)
Int J Radiat Oncol Biol Phys
, vol.44
, pp. 1125-1135
-
-
Mason, K.A.1
Milas, L.2
Hunter, N.R.3
-
13
-
-
0034306137
-
Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity
-
Talamonti M.S., Catalano P.J., Vaughn D.J., et al. Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer A regimen with unexpected early toxicity . J Clin Oncol. 18:2000;3384-3389.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3384-3389
-
-
Talamonti, M.S.1
Catalano, P.J.2
Vaughn, D.J.3
-
14
-
-
8244254377
-
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
-
Burris H.A. III, Moore M.J., Andersen J., et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer A randomized trial . J Clin Oncol. 15:1997;2403-2413.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2403-2413
-
-
Burris H.A. III1
Moore, M.J.2
Andersen, J.3
-
15
-
-
0035890443
-
A phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer
-
McGinn C.J., Zalupski M.M., Shureiqi I., et al. A phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 19:2001;4202-4208.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4202-4208
-
-
McGinn, C.J.1
Zalupski, M.M.2
Shureiqi, I.3
-
16
-
-
0023120714
-
Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer
-
Gunderson L.L., Martin J.K., Kvols L.K., et al. Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 13:1987;319-329.
-
(1987)
Int J Radiat Oncol Biol Phys
, vol.13
, pp. 319-329
-
-
Gunderson, L.L.1
Martin, J.K.2
Kvols, L.K.3
-
17
-
-
0026649462
-
The clinical application of a non-axial treatment plan for pancreatic and biliary malignancies
-
Robertson J.M., Marsh L., TenHaken R.K., et al. The clinical application of a non-axial treatment plan for pancreatic and biliary malignancies. Radiother Oncol. 24:1992;198-200.
-
(1992)
Radiother Oncol
, vol.24
, pp. 198-200
-
-
Robertson, J.M.1
Marsh, L.2
TenHaken, R.K.3
-
18
-
-
0028894319
-
Three-dimensional conformal pancreas treatment: Comparison of four- to six-field techniques
-
Higgins P.D., Sohn J.W., Fine R.M., et al. Three-dimensional conformal pancreas treatment Comparison of four- to six-field techniques . Int J Radiat Oncol Biol Phys. 31:1995;605-609.
-
(1995)
Int J Radiat Oncol Biol Phys
, vol.31
, pp. 605-609
-
-
Higgins, P.D.1
Sohn, J.W.2
Fine, R.M.3
-
19
-
-
0029639928
-
Recent advances in radiation oncology
-
Lichter A.S., Lawrence T.S. Recent advances in radiation oncology. N Engl J Med. 332:1995;371-379.
-
(1995)
N Engl J Med
, vol.332
, pp. 371-379
-
-
Lichter, A.S.1
Lawrence, T.S.2
|